Michael A. Carrier

Rutgers Law School

Distinguished Professor

217 North Fifth Street

Camden, NJ 08102-1203

United States

SCHOLARLY PAPERS

144

DOWNLOADS
Rank 570

SSRN RANKINGS

Top 570

in Total Papers Downloads

40,590

SSRN CITATIONS
Rank 10,588

SSRN RANKINGS

Top 10,588

in Total Papers Citations

22

CROSSREF CITATIONS

90

Scholarly Papers (144)

1.

Copyright and Innovation: The Untold Story

2012 Wisconsin Law Review 891
Number of pages: 72 Posted: 04 Jul 2012 Last Revised: 04 Dec 2012
Michael A. Carrier
Rutgers Law School
Downloads 7,947 (805)
Citation 1

Abstract:

Loading...

copyright, innovation, music, peer-to-peer (p2p), venture capital, napster, Innovator's Dilemma, record labels, SOPA, PIPA, statutory damages, personal liability

2.

A Roadmap to the Smartphone Patent Wars and FRAND Licensing

CPI Antitrust Chronicle, Vol. 2, April 2012
Number of pages: 7 Posted: 04 May 2012
Michael A. Carrier
Rutgers Law School
Downloads 3,302 (3,729)
Citation 1

Abstract:

Loading...

Smartphones, patents, patent wars, standards, RAND, FRAND, antitrust

3.

Cabining Intellectual Property Through a Property Paradigm

Number of pages: 145 Posted: 30 Apr 2004
Michael A. Carrier
Rutgers Law School
Downloads 1,859 (9,846)
Citation 2

Abstract:

Loading...

Intellectual property, property, propertization, patent, copyright, trademark, right of publicity

4.

Against Cyberproperty

Berkeley Technology Law Journal, Vol. 22, 2007
Number of pages: 36 Posted: 25 Apr 2007 Last Revised: 06 Apr 2008
Michael A. Carrier and Greg Lastowka
Rutgers Law School and Rutgers School of Law
Downloads 1,178 (20,016)

Abstract:

Loading...

cyberproperty, property, cyberspace, Locke, Hegel, utilitarianism, spam, electronic invasion, copyright

5.

The Untold EpiPen Story: How Mylan Hiked Prices by Blocking Rivals

102 Cornell Law Review Online 53 (2017)
Number of pages: 20 Posted: 21 Sep 2016 Last Revised: 01 Feb 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 1,064 (23,303)
Citation 1

Abstract:

Loading...

EpiPen, Mylan, antitrust, settlement, citizen petition, exclusive dealing, Teva

6.

Innovation for the 21st Century: Harnessing the Power of Intellectual Property and Antitrust Law

Oxford University Press, 2009
Number of pages: 16 Posted: 27 Mar 2009
Michael A. Carrier
Rutgers Law School
Downloads 820 (33,805)

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

7.

Using Antitrust Law to Challenge Turing's Daraprim Price Increase

31 Berkeley Technology Law Journal 1379 (2017)
Number of pages: 30 Posted: 29 Jan 2016 Last Revised: 14 Jul 2017
Michael A. Carrier, Nicole Levidow and Aaron S. Kesselheim
Rutgers Law School, Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics and Brigham and Women's Hospital/Harvard Medical School
Downloads 686 (43,058)

Abstract:

Loading...

Turing, Shkreli, antitrust, monopolization, drugs, pharmaceuticals, Daraprim, pyrimethamine

8.

Two Puzzles Resolved: Of the Schumpeter - Arrow Stalemate and Pharmaceutical Innovation Markets

Iowa Law Review, Vol. 93, 2008
Number of pages: 58 Posted: 09 Apr 2007 Last Revised: 02 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 675 (44,043)

Abstract:

Loading...

antitrust, innovation market, schumpeter, arrow, market structure, innovation, mergers, patents, pharmaceuticals

9.

A Real-World Analysis of Pharmaceutical Settlements: The Missing Dimension of Product-Hopping

Florida Law Review, Vol. 62, 2010
Number of pages: 28 Posted: 14 Apr 2010 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 672 (44,303)
Citation 3

Abstract:

Loading...

patent, antitrust, settlement, product hopping, drugs, pharmaceuticals, Hatch Waxman, reverse payments

10.

The Pirate Bay, Grokster, and Google

Journal of Intellectual Property Rights, Vol. 15, pp. 7-18, January 2010
Number of pages: 12 Posted: 04 Oct 2009 Last Revised: 27 Oct 2012
Michael A. Carrier
Rutgers Law School
Downloads 666 (44,828)
Citation 2

Abstract:

Loading...

The Pirate Bay, Google, Grokster, copyright, file-sharing, P2P, BitTorrent, secondary liability, piracy, infringement

11.

Patent Assertion Entities: Six Actions the Antitrust Agencies Can Take

CPI Antitrust Chronicle, Winter 2013, Vol. 1 No. 2
Number of pages: 12 Posted: 31 Jan 2013
Michael A. Carrier
Rutgers Law School
Downloads 649 (46,421)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust

12.

RAND Patents and Exclusion Orders: Submission of 19 Economics and Law Professors to the International Trade Commission

Santa Clara Univ. Legal Studies Research Paper No. 07-12, UC Berkeley Public Law Research Paper No. 2102865
Number of pages: 13 Posted: 10 Jul 2012
Santa Clara University - School of Law, University of California, Berkeley - Department of Economics, University of California, Berkeley - Haas School of Business, University of Minnesota Law School, Notre Dame Law School, Syracuse University College of Law, Santa Clara University - School of Law, University of California, Irvine School of Law, Pennsylvania State University - Mary Jean and Frank P. Smeal College of Business Administration, Rutgers Law School, University of Utah - S.J. Quinney College of Law, University of Georgia School of Law, Villanova University Charles Widger School of Law, New York University School of Law, University of San Diego School of Law, Duke University School of Law, New York University School of Law, University of Leuven and University of Nebraska - College of Law
Downloads 619 (49,367)
Citation 1

Abstract:

Loading...

13.

No, RIAA, It's Not the End of the World for Musicians

University of Missouri-Kansas City Law Review, 2014
Number of pages: 16 Posted: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 610 (50,317)

Abstract:

Loading...

music, musicians, copyright, GarageBand, Twitter, YouTube, Topspin, Bandcamp, CD Baby Pro, TuneCore, Kickstarter, Indiegogo, Songkick, Bandsintown

14.

Resolving the Patent-Antitrust Paradox Through Tripartite Innovation

Number of pages: 65 Posted: 19 Feb 2003
Michael A. Carrier
Rutgers Law School
Downloads 573 (54,491)
Citation 3

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

15.

What You Need to Know About Standard Essential Patents

Competition Policy International (Vol. 8, No. 2, 2014)
Number of pages: 10 Posted: 27 Aug 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 549 (57,513)

Abstract:

Loading...

Standard essential patents, SEPs, RAND, FRAND, antitrust, injunctions

16.

Unsettling Drug Patent Settlements: A Framework for Presumptive Illegality

Michigan Law Review, Vol. 108
Number of pages: 44 Posted: 11 Mar 2009 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 536 (59,252)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

17.

Product Hopping: A New Framework

92 Notre Dame Law Review, 167 (2016)
Number of pages: 65 Posted: 16 Mar 2016 Last Revised: 25 Feb 2017
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 528 (60,399)
Citation 1

Abstract:

Loading...

product hopping, pharmaceuticals, drugs, antitrust, no economic sense, reformulations, Hatch Waxman, state DPS laws

18.

Biologics: The New Antitrust Frontier

2018 U. Ill. L. Rev. 1 (2018)
Number of pages: 70 Posted: 08 Jun 2017 Last Revised: 31 Jan 2018
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 499 (64,803)

Abstract:

Loading...

biologics, BPCIA, antitrust, settlements, product hopping, REMS, citizen petitions, disparagement, collusion

19.

Citizen Petitions: Long, Late-Filed, and At-Last Denied

66 American University Law Review 305 (2016)
Number of pages: 48 Posted: 30 Aug 2016 Last Revised: 02 Jan 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 496 (65,314)
Citation 4

Abstract:

Loading...

citizen petition, pharmaceuticals, drugs, 505(q), brands, generics, Copaxone, Mirena, Doryx, EpiPen

20.

A Tort-Based Causation Framework for Antitrust Analysis

Antitrust Law Journal, Forthcoming
Number of pages: 26 Posted: 15 Oct 2011 Last Revised: 17 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 444 (74,789)

Abstract:

Loading...

causation, antitrust, tort, monopolization, antitrust injury

21.

Payment after Actavis

100 Iowa Law Review 7 (2014)
Number of pages: 43 Posted: 02 Apr 2014 Last Revised: 30 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 441 (75,384)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, poison pill, acceleration clauses, authorized generics

22.

The Rule of Reason: An Empirical Update for the 21st Century

George Mason Law Review, Vol. 16, No. 827, 2009
Number of pages: 11 Posted: 29 Sep 2009 Last Revised: 04 Oct 2009
Michael A. Carrier
Rutgers Law School
Downloads 428 (78,155)
Citation 3

Abstract:

Loading...

antitrust, rule of reason, balancing, anticompetitive effects, procompetitive justifications

23.

How Not to Apply the Rule of Reason: The O’Bannon Case

114 Michigan Law Review First Impressions 73 (2015)
Number of pages: 8 Posted: 11 Oct 2015 Last Revised: 02 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 427 (78,378)

Abstract:

Loading...

NCAA, O'Bannon, college sports, amateurism, antitrust, Rule of Reason, less restrictive alternatives, balancing

24.

Citizen Petitions: An Empirical Study

Cardozo Law Review, Forthcoming
Number of pages: 46 Posted: 04 Jun 2012 Last Revised: 30 Jul 2013
Michael A. Carrier and Daryl Wander
Rutgers Law School and affiliation not provided to SSRN
Downloads 416 (80,834)

Abstract:

Loading...

citizen petitions, pharmaceutical, patent, antitrust, FDA, generics

25.

Google and Antitrust: Five Approaches to an Evolving Issue

Harvard Journal of Law & Technology Occasional Paper Series - July 2013
Number of pages: 14 Posted: 02 Aug 2013
Michael A. Carrier
Rutgers Law School
Downloads 407 (82,892)

Abstract:

Loading...

Google, antitrust, search neutrality, Google Book search, FTC

26.

Unraveling the Patent-Antitrust Paradox

University of Pennsylvania Law Review, Vol. 150, January 2002
Number of pages: 94 Posted: 30 Apr 2002
Michael A. Carrier
Rutgers Law School
Downloads 390 (87,070)
Citation 1

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

27.

Playing Both Sides: Branded Sales, Generic Drugs, and Antitrust Policy

Stanford Law and Economics Olin Working Paper No. 533, 71 Hastings Law Journal 307 (2020), Rutgers Law School Research Paper
Number of pages: 52 Posted: 12 Mar 2019 Last Revised: 21 Feb 2020
Michael A. Carrier, Mark A. Lemley and Shawn P. Miller
Rutgers Law School, Stanford Law School and University of San Diego School of Law
Downloads 372 (92,044)
Citation 1

Abstract:

Loading...

antitrust, mergers, pharmaceuticals, empirical studies, generics

28.

Why Antitrust Should Defer to the Intellectual Property Rules of Standard-Setting Organizations: A Commentary on Teece & Sherry

Minnesota Law Review, Vol. 87, p. 2019, 2003
Number of pages: 20 Posted: 05 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 350 (98,641)

Abstract:

Loading...

antitrust, intellectual property, standards, standard-setting organizations

29.

Refusals to License Intellectual Property after Trinko

DePaul Law Review, Vol. 55, p. 1191, 2006
Number of pages: 20 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 345 (100,228)
Citation 1

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

30.

Sharing, Samples, and Generics: An Antitrust Framework

103 Cornell Law Review 1 (2017)
Number of pages: 64 Posted: 04 Jun 2017 Last Revised: 22 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 324 (107,552)

Abstract:

Loading...

antitrust, patent, pharmaceuticals, drugs, samples, REMS

31.

Why the 'Scope of the Patent' Test Cannot Solve the Drug Patent Settlement Problem

Stanford Technology Law Review, Vol. 16, No. 1, 2012
Number of pages: 8 Posted: 15 Sep 2012
Michael A. Carrier
Rutgers Law School
Downloads 318 (109,746)
Citation 2

Abstract:

Loading...

patents, antitrust, pharmaceuticals, settlements, patent scope

32.

SOPA, PIPA, ACTA, TPP: An Alphabet Soup of Innovation-Stifling Copyright Legislation and Agreements

Northwestern Journal of Technology and Intellectual Property, Vol. 11, No. 2, 2013
Number of pages: 14 Posted: 07 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 313 (111,647)

Abstract:

Loading...

copyright, innovation, secondary liability, Stop Online Piracy Act (SOPA), PROTECT IP Act (PIPA), Anti-Counterfeiting Trade Agreement (ACTA), Trans-Pacific Partnership Agreement (TPP)

33.

Pharmaceutical Antitrust: What the Trump Administration Can Do

Concurrences: Competition Law Review 63 (No. 4, 2016)
Number of pages: 3 Posted: 05 Dec 2016
Michael A. Carrier
Rutgers Law School
Downloads 292 (120,219)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, patents, FDA, settlements, product hopping, REMS

34.

Antitrust in the Pharmaceutical Sector: An Overview of U.S. Case Law

e-Competitions Bulletin, No. 88026, Nov. 2018
Number of pages: 10 Posted: 11 Nov 2018
Michael A. Carrier
Rutgers Law School
Downloads 281 (125,187)

Abstract:

Loading...

Pharmaceutical, Antitrust, Settlements, Product Hopping, Sample Denials, Citizen Petitions, Rebates/Bundling

35.

Brief Amici Curiae of 118 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Petitioners

Supreme Court amicus brief in FTC v. Watson, 2013
Number of pages: 62 Posted: 30 Jan 2013
Michael A. Carrier and Mark A. Lemley
Rutgers Law School and Stanford Law School
Downloads 272 (129,587)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Hatch Waxman, reverse payments, exclusion payments, Androgel

36.

Three Challenges for Pharmaceutical Antitrust

59 Santa Clara Law Review 613 (2020) (symposium), Rutgers Law School Research Paper
Number of pages: 25 Posted: 27 Mar 2019 Last Revised: 23 Feb 2020
Michael A. Carrier
Rutgers Law School
Downloads 271 (130,114)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, settlements, product hopping, citizen petitions, sample denials, REMS

37.

Big Tech, Antitrust, and Breakup

Georgetown Journal of International Affairs (Jan. 2020)
Number of pages: 4 Posted: 27 May 2020
Michael A. Carrier
Rutgers Law School
Downloads 269 (131,116)

Abstract:

Loading...

antitrust, Big Tech, Amazon, Apple, Facebook, Google

38.

Pharmaceutical Antitrust Complexity

CPI Antitrust Chronicle (Nov. 2014)
Number of pages: 12 Posted: 25 Nov 2014
Michael A. Carrier
Rutgers Law School
Downloads 257 (137,430)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, complexity, settlements, product hopping, generics

39.

Solving the Drug Settlement Problem: The Legislative Approach

Rutgers Law Journal, Vol. 41, pp. 81, 2009, Lawyers, Drugs & Money Symposium, Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry
Number of pages: 21 Posted: 23 Dec 2009 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 250 (141,247)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

40.

The Real Rule of Reason: Bridging the Disconnect

Brigham Young University Law Review, Vol. 1999, p. 1265
Number of pages: 102 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 238 (148,151)
Citation 3

Abstract:

Loading...

Rule of Reason, balancing, anticompetitive effects, procompetitive justifications

41.

The D.C. Circuit’s Excessively High Causation Standard in Rambus

Number of pages: 25 Posted: 08 Apr 2010 Last Revised: 25 May 2014
Michael A. Carrier
Rutgers Law School
Downloads 234 (150,556)

Abstract:

Loading...

Antitrust, Standard-Setting, Causation, Rambus, Monopolization, Discon

42.

Pleading Standards: The Hidden Threat to Actavis

91 New York University Law Review Online 31 (2016)
Number of pages: 12 Posted: 21 May 2016 Last Revised: 22 May 2016
Michael A. Carrier
Rutgers Law School
Downloads 232 (151,776)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, pleading, Twombly, Iqbal, Actavis, Effexor, Lipitor

43.

Five Solutions to the REMS Patent Problem

97 Boston University Law Review 1661 (2017)
Number of pages: 47 Posted: 05 Jul 2017 Last Revised: 05 Oct 2017
Michael A. Carrier and Brenna Sooy
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 231 (152,394)

Abstract:

Loading...

Patent, Drugs, Pharmaceuticals, REMS, FDA

44.

Of Trinko, Tea Leaves, and Intellectual Property

Journal of Corporation Law, Vol. 31, 2005
Number of pages: 17 Posted: 28 Feb 2006
Michael A. Carrier
Rutgers Law School
Downloads 229 (153,706)

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

45.

U.S. Court Upholds Antitrust Action Against Patent Troll

e-Competitions Bulletin, No. 73428, May 2015
Number of pages: 5 Posted: 13 Jun 2015
Michael A. Carrier
Rutgers Law School
Downloads 222 (158,332)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust, Intellectual Ventures, Capital One

46.

An Antitrust Framework for Climate Change

Northwestern Journal of Technology and Intellectual Property, Vol. 9, No. 8, p. 513, 2011
Number of pages: 22 Posted: 10 Sep 2011
Michael A. Carrier
Rutgers Law School
Downloads 214 (163,918)

Abstract:

Loading...

antitrust, climate change, markets, standards, patent pools, Smart Grid, Eco-Patent Commons, Green Xchange

47.

Vote Counting, Technology, and Unintended Consequences

St. John's Law Review, Vol. 69, 2005
Number of pages: 43 Posted: 30 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 206 (170,021)

Abstract:

Loading...

Electronic voting, vote counting, computerization, technology, HAVA, 2004 election

48.

Post-Grant Opposition: A Proposal and a Comparison to the America Invents Act

UC Davis Law Review, Vol. 45 (2011)
Number of pages: 33 Posted: 14 Mar 2011 Last Revised: 11 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 201 (174,019)

Abstract:

Loading...

patents, patent reform, post-grant opposition, America Invents Act

49.
Downloads 193 (180,548)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP

50.

Eight Reasons Why 'No-Authorized-Generic' Promises Constitute Payment

67 Rutgers University Law Review 697 (2015)
Number of pages: 24 Posted: 05 Dec 2014 Last Revised: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 179 (193,040)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, authorized generics, Lamictal, Loestrin

51.

A US Court Issues Second Ruling Determining RAND Rate for Standard Essential Patent (Innovatio)

e-Competitions Bulletin, No 58558, 2013
Number of pages: 6 Posted: 24 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 176 (195,900)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP, WiFi

52.

Provigil: A Case Study of Anticompetitive Behavior

Hastings Science & Technology Law Journal, Vol. 3, No. 2, pp. 441-452, Summer 2011
Number of pages: 12 Posted: 15 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 172 (199,777)

Abstract:

Loading...

patent, antitrust, settlements, product hopping, drugs, Hatch Waxman, Provigil, Cephalon

53.

Innovation for the 21st Century: A Response to Seven Critics

61 Alabama Law Review, Vol. 61, p. 597, 2010
Number of pages: 31 Posted: 11 Oct 2009 Last Revised: 30 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 166 (205,977)

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

54.

O’Bannon v. National Collegiate Athletic Association: Why the Ninth Circuit Should Not Block the Floodgates of Change in College Athletics

71 Wash. & Lee L. Rev. Online 299, Cleveland-Marshall Legal Studies Paper No. 2575764
Number of pages: 13 Posted: 10 Mar 2015
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 164 (208,061)

Abstract:

Loading...

NCAA, O'Bannon, college sports, right of publicity, antitrust, rule of reason, amateurism, less restrictive alternatives

55.

How Not to Apply Actavis

Northwestern University Law Review Online, Vol. 109, 2014
Number of pages: 18 Posted: 16 Nov 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 162 (210,263)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, Lamictal, Loestrin, reverse payments, exclusion payments

56.

Why Modularity Does Not (and Should Not) Explain Intellectual Property

Yale Law Journal Pocket Part, Vol. 117, p. 95, 2007
Number of pages: 6 Posted: 04 Feb 2008
Michael A. Carrier
Rutgers Law School
Downloads 161 (211,359)

Abstract:

Loading...

intellectual property, property, modularity, patents, copyrights

57.

U.S. Court Finds that an Athletics Association's Rules Restricting Payments to Student-Athletes Violate Antitrust Laws (O’Bannon v. NCAA)

e-Competitions Bulletin, No. 68725, Sept. 2014
Number of pages: 8 Posted: 19 Sep 2014
Michael A. Carrier
Rutgers Law School
Downloads 157 (215,884)

Abstract:

Loading...

sports, antitrust, NCAA, right of publicity

58.

Brief Amici Curiae of 82 Law, Economics, Business, and Medical Professors in Support of Respondent

U.S. Court of Appeals for the Fifth Circuit, 2019
Number of pages: 43 Posted: 16 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 156 (217,050)

Abstract:

Loading...

patent, antitrust, Actavis, pay-for-delay, reverse payment, settlement, Impax

59.

What Is Trump Antitrust?

Concurrences, No. 4, 2016
Number of pages: 26 Posted: 01 Dec 2016
Microsoft Corporation, Sheppard, Mullin, Richter & Hampton LLP, Axinn Veltrop & Harkrider, LLP, Government of the United States of America - Federal Trade Commission, Orrick, Herrington & Sutcliffe, LLP, American Antitrust Institute (AAI), Dechert LLP, Hogan Lovells, Hogan Lovells, Qualcomm, Inc., Bingham McCutchen, LLP, Paul, Weiss, Rifkind, Wharton & Garrison LLP, Skadden, Arps, Slate, Meagher & Flom LLP, General Electric Company, University of California, Berkeley - Department of Economics, Northeastern University - Department of Economics, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Loyola University Chicago School of Law, Willkie Farr & Gallagher LLP, Willkie Farr & Gallagher LLP, Rutgers Law School, Hausfeld, Hausfeld and Hausfeld
Downloads 156 (217,050)

Abstract:

Loading...

United States, Antitrust Policy, Presidential Election, Mergers, Cartels, Monopolization, International Cooperation, European Union

60.

Why a 'Large and Unjustified' Payment Threshold is Not Consistent with Actavis

91 Washington Law Review 109 (2016)
Number of pages: 10 Posted: 23 Sep 2015 Last Revised: 05 Apr 2016
Michael A. Carrier
Rutgers Law School
Downloads 152 (221,766)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, large and unjustified payment, reverse payments, exclusion payments, Rule of Reason

61.
Downloads 151 (223,026)

The Four-Step Rule of Reason

33 Antitrust 50 (2019), Rutgers Law School Research Paper
Number of pages: 6 Posted: 01 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 138 (240,586)

Abstract:

Loading...

antitrust, Rule of Reason, balancing

The Four-Step Rule of Reason

33 Antitrust 50 (2019)
Number of pages: 6 Posted: 23 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 13 (666,217)

Abstract:

Loading...

antitrust, Rule of Reason, O'Bannon, Amex

62.

Five Arguments Laid to Rest after Actavis

Antitrust Source, Vol. 13 No. 1 (October 2013)
Number of pages: 11 Posted: 06 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 146 (229,154)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, patent scope

63.

A Response to Chief Justice Roberts: Why Antitrust Must Play a Role in the Analysis of Drug Patent Settlements

15 Minnesota Journal of Law, Science & Technology 31 (2014)
Number of pages: 10 Posted: 22 Sep 2013 Last Revised: 08 Mar 2014
Michael A. Carrier
Rutgers Law School
Downloads 146 (229,154)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

64.

A Non-Coercive Approach to Product Hopping

33 Antitrust 102 (2018), Rutgers Law School Research Paper
Number of pages: 6 Posted: 16 Jan 2019
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 145 (230,386)

Abstract:

Loading...

product hopping, pharmaceuticals, antitrust, drugs, innovation

65.

The US Supreme Court Issues First Ruling on Antitrust Legality of Reverse-Payment Drug Patent Settlements (Actavis)

e-Competitions Bulletin, No. 53120, July 2013
Number of pages: 6 Posted: 16 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 144 (231,638)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, Hatch Waxman, brands, generics

66.

Pictures at the New Economy Exhibition: Why the Antitrust Modernization Commission Got it (Mostly) Right

38 Rutgers Law Journal 473 (2007)
Number of pages: 20 Posted: 09 Jul 2007 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 143 (232,969)

Abstract:

Loading...

antitrust, new economy, Antitrust Modernization Commission (AMC), intellectual property, patents, innovation

67.

Brief Amici Curiae of 53 Law, Economics, and Business Professors, the American Antitrust Institute, and Consumers Union in Support of Appellants

Third Circuit brief in In re: Lamictal Direct Purchaser Antitrust Litigation, 2014
Number of pages: 41 Posted: 29 Apr 2014
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 134 (245,549)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Lamictal

68.

A US Court Issues Formalistic Ruling on Reverse-Payment Settlements After 'Actavis' (GlaxoSmithKline/Teva Pharmaceuticals/Louisiana Wholesale Drug Company/King Drug Company)

e-Competitions Bulletin, No. 63588, February 2014
Number of pages: 5 Posted: 17 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 133 (247,015)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, patent, antitrust, Actavis, Hatch Waxman, brands, generics, authorized generics

69.

Five Actions to Stop Citizen Petition Abuse

118 Columbia Law Review Online 81 (2018)
Number of pages: 12 Posted: 28 Sep 2017 Last Revised: 09 Mar 2018
Michael A. Carrier
Rutgers Law School
Downloads 125 (258,866)

Abstract:

Loading...

citizen petitions, pharmaceuticals, drugs, FDA

70.

Only 'Scraping' the Surface: The Copyright Hole in the FTC's Google Settlement

46 UBC Law Review (2013)
Number of pages: 19 Posted: 07 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 123 (262,012)

Abstract:

Loading...

copyright, antitrust, Google, scraping, fair use, misappropriation, Yelp, reviews

71.

The Business of Amateurs: Suffering Student-Athletes and a Thriving NCAA

Number of pages: 2 Posted: 13 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 121 (265,288)

Abstract:

Loading...

sports, college, NCAA, football, basketball, amateurism

72.

When is the Senate in Recess for Purposes of the Recess Appointments Clause?

Michigan Law Review, Vol. 92, No. 7, 1994
Number of pages: 44 Posted: 12 Jul 2007
Michael A. Carrier
Rutgers Law School
Downloads 119 (268,551)

Abstract:

Loading...

Recess Appointments Clause, recess, intersession, intrasession

73.

The Rule of Reason in the Post-Actavis World

2018 Columbia Business Law Review 26
Number of pages: 20 Posted: 23 May 2018
Michael A. Carrier
Rutgers Law School
Downloads 118 (270,151)

Abstract:

Loading...

settlements, pharmaceuticals, drugs, Actavis, Taft, Rule of Reason, O'Bannon, Addyston Pipe, Wellbutrin

74.

High Prices & No Excuses: 6 Anticompetitive Games (Presentation Slides)

Testimony for FTC Workshop on “Understanding Competition in Prescription Drug Markets”, 2017
Number of pages: 10 Posted: 08 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 118 (270,151)

Abstract:

Loading...

Drugs, Pharmaceuticals, Patent, Antitrust

75.

The Curious Case of Wellbutrin: How the Third Circuit Mistook Itself for the Supreme Court

103 Cornell L. Rev. Online 137 (2018)
Number of pages: 12 Posted: 29 Aug 2017 Last Revised: 17 Apr 2018
Michael A. Carrier
Rutgers Law School
Downloads 112 (280,287)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, drugs, settlements, reverse payments, risk aversion, Wellbutrin

76.

Brief of Thirty-Four Law Professors as Amici Curiae in Support of Appellants in Altera Corp. v. Papst Licensing GMBH

Southwestern Law School Research Paper No. 2015-25
Number of pages: 28 Posted: 22 Dec 2015 Last Revised: 06 Jan 2021
Southwestern Law School, University at Buffalo Law School, Tulane University Law School, Creighton University School of Law, Yeshiva University - Benjamin N. Cardozo School of Law, Rutgers Law School, University of Denver Sturm College of Law, Santa Clara University - School of Law, University of Utah - S.J. Quinney College of Law, University of California Hastings College of the Law, University of Kentucky - College of Law, Elon University School of Law, University of California, Davis, University of New Hampshire Franklin Pierce School of Law, Suffolk University Law School, Temple University - James E. Beasley School of Law, Emory University, University of Baltimore - School of Law, University of Houston Law Center, Catholic University of America (CUA) - Columbus School of Law, Stanford Law School, UC Hastings Law, University of Georgia School of Law, St. Thomas University School of Law, St. Thomas University School of Law, Indiana University Robert H. McKinney School of Law, Center for Intellectual Property & Innovation, Michigan State University College of Law, South Texas College of Law, Case Western Reserve University School of Law, Washington and Lee University School of Law, University of St. Thomas School of Law (Minnesota), Florida International University (FIU) - College of Law, Simpson Thacher & Bartlett LLP and University of Pennsylvania Law School - Student/Alumni/Adjunct
Downloads 111 (281,975)

Abstract:

Loading...

patent, declaratory judgment, jurisdiction, personal jurisdiction, patent assertion entity, minimum contacts

77.

An Antitrust Framework for False Advertising

Iowa Law Review, Forthcoming, Rutgers Law School Research Paper, Harvard Public Law Working Paper No. 20-16
Number of pages: 42 Posted: 27 May 2020 Last Revised: 23 Oct 2020
Michael A. Carrier and Rebecca Tushnet
Rutgers Law School and Harvard Law School
Downloads 110 (283,774)

Abstract:

Loading...

antitrust, false advertising, monopoly, biosimilars

78.

Brief of Amici Curiae 49 Professors in Support of Petitioners

California Supreme Court brief in In re Cipro Cases I & II, 2014
Number of pages: 47 Posted: 19 Mar 2014
Michael A. Carrier and Judith Zahid
Rutgers Law School and Zelle Hofmann Voelbel & Mason LLP
Downloads 106 (291,379)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

79.

Four Innovation Myths

Concurrences (Albert A. Foer Liber Amicorum), Forthcoming
Number of pages: 25 Posted: 22 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 97 (309,028)

Abstract:

Loading...

innovation, patent holdup, FRAND, cumulative innovation, innovation markets, statutory damages

80.

The US Federal Trade Commission Issues Report on Patent Assertion Entities

e-Competitions Bulletin, No. 82367, December 2016
Number of pages: 7 Posted: 12 Jan 2017
Michael A. Carrier
Rutgers Law School
Downloads 97 (309,028)

Abstract:

Loading...

PAE, Patent Assertion Entity, Troll, FTC, Antitrust, Patent

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit brief in In re: Effexor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 18 Nov 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 57 (422,997)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Effexor

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit Brief In re: Lipitor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 29 Dec 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 40 (493,350)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, damages forgiveness, Hatch Waxman Act, Lipitor

82.

2025: Reverse-Payment Settlements Unleashed

Competition Policy International Antitrust Journal, Vol. 2, December 2010
Number of pages: 5 Posted: 16 Jan 2011
Michael A. Carrier
Rutgers Law School
Downloads 93 (317,385)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, reverse payments, Hatch Waxman

83.

Rescuing Antitrust’s Role in Patent Holdup

168 U. Pa. L. Rev. Online, Forthcoming
Number of pages: 12 Posted: 19 Jun 2020
Michael A. Carrier
Rutgers Law School
Downloads 91 (321,830)

Abstract:

Loading...

standards, patents, antitrust, holdup

84.

Reverse-Payment Settlement Agreements Roundtable

ABA Antitrust Health Care Chronicle, 2013
Number of pages: 21 Posted: 13 Apr 2013 Last Revised: 05 May 2015
Michael A. Carrier, Howard Morse, Eric Stock, Kent Bernard and Karen Bokat
Rutgers Law School, Cooley Godward Kronish LLP, Hogan Lovells, Fordham University School of Law and Wiley Rein & Fielding LLP
Downloads 91 (321,830)

Abstract:

Loading...

drug patents, reverse payments, settlements, patent, antitrust, pharmaceuticals, Hatch Waxman Act

85.

A U.S. Court Sends Second Reverse-Payment Case to Trial (Cephalon)

e-Competitions Bulletin, No. 71871, January 2015
Number of pages: 5 Posted: 24 Mar 2015
Michael A. Carrier
Rutgers Law School
Downloads 90 (324,083)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, "large and unjustified," settlement, reverse payments, exclusion payments, Cephalon

86.

What Does State Law Say About Drug Patent Settlements? The California Supreme Court's Cipro Case

Antitrust Health Care Chronicle (April 2015)
Number of pages: 12 Posted: 21 Apr 2015
Michael A. Carrier
Rutgers Law School
Downloads 89 (326,379)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

87.

Limiting Copyright Through Property

Forthcoming in Concepts of Property in Intellectual Property (Cambridge 2013)
Number of pages: 17 Posted: 25 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 88 (328,777)

Abstract:

Loading...

copyright, property, propertization, rights

88.

College Athletics: The Chink in the Seventh Circuit's 'Law and Economics' Armor

117 Michigan Law Review Online 90 (2019), Rutgers Law School Research Paper
Number of pages: 14 Posted: 26 Feb 2019 Last Revised: 12 Nov 2019
Michael A. Carrier and Marc Edelman
Rutgers Law School and City University of New York - Baruch College, Zicklin School of Business
Downloads 85 (335,880)

Abstract:

Loading...

NCAA, College Sports, Antitrust, Amateurism, Student-Athletes, Rule of Reason

89.

2008 and 2015: Night and Day for Drug Patent Settlements

CPI Antitrust Chronicle, Dec. 2015
Number of pages: 8 Posted: 16 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 85 (335,880)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, scope-of-patent, Actavis, Lamictal, Cipro, Cephalon, FTC, reverse payments, exclusion payments

90.

The NCAA's Exploitation of Student-Athletes

Sports Law Blog, 2016
Number of pages: 2 Posted: 24 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 82 (343,128)

Abstract:

Loading...

NCAA, amateurism, student-athlete

91.

Front Matter and Introduction to: Intellectual Property and Competition

Edward Elgar Publishing, 2011
Number of pages: 20 Posted: 18 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 79 (350,747)

Abstract:

Loading...

antitrust, competition, intellectual property

92.

Amici Curiae Brief of 66 Law, Economics, Business, and Medical Professors in Support of Plaintiffs-Appellants

Seventh Circuit brief in UFCW Local 1500 Welfare Fund v. AbbVie Inc.
Number of pages: 35 Posted: 09 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 78 (353,379)

Abstract:

Loading...

antitrust, patent, thicket, Humira, settlement, pay for delay, sham litigation

93.

Brief Amici Curiae of 58 Law, Economics, and Business Professors in Support of Appellants' Petition for Panel Rehearing or Rehearing En Banc

Third Circuit brief in In re Wellbutrin XL Antitrust Litigation, 2017
Number of pages: 23 Posted: 07 Sep 2017
Michael A. Carrier
Rutgers Law School
Downloads 77 (355,993)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, risk aversion, Actavis, Wellbutrin

94.

Corrected Brief of Amici Curiae Fifty-Seven Law, Economics, Business, Health, and Medicine Professors in Support of Cross-Appellant's Petition for Rehearing En Banc

Federal Circuit brief in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.
Number of pages: 34 Posted: 23 Dec 2020 Last Revised: 04 Jan 2021
Michael A. Carrier, Matthew J Dowd and Robert Scheffel
Rutgers Law School, Dowd Scheffel PLLC and affiliation not provided to SSRN
Downloads 72 (369,649)

Abstract:

Loading...

patent, skinny label, section viii, Hatch-Waxman Act, generics

95.

Actavis and 'Large and Unjustified' Payments

SCOTUSblog, 2013
Number of pages: 5 Posted: 30 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 71 (372,487)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, pay for delay

96.

Limelight v. Akamai: Limiting Induced Infringement

Wisconsin Law Review online, 2014:1
Number of pages: 8 Posted: 22 Jul 2014
Michael A. Carrier
Rutgers Law School
Downloads 70 (375,463)

Abstract:

Loading...

patent, inducement, infringement, Akamai, Limelight, Federal Circuit

97.

Increasing Innovation Through Copyright Common Sense and Better Government Policy

Emory Law Journal, Vol. 62, No. 983, 2013
Number of pages: 15 Posted: 03 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 70 (375,463)

Abstract:

Loading...

innovation, copyright, immigration, tax, STEM, statutory damages, personal liability, R&D tax credit, basic research

98.

The U.S. Court of Appeals for the First Circuit Concludes that a Reverse Payment Need Not Be in Cash (Loestrin)

e-Competitions Bulletin, No. 78533, March 2016
Number of pages: 5 Posted: 21 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 69 (378,333)

Abstract:

Loading...

antitrust, patent, Hatch Waxman, drugs, pharmaceuticals, reverse payments, pay for delay

99.

Foreword: After Actavis: Seven Ways Forward

67 Rutgers University Law Review 543 (2015)
Number of pages: 13 Posted: 09 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 69 (378,333)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, Actavis, drug patent settlements, reverse payments, Actavis inference, jury instructions, authorized generics, Cipro, Noerr-Pennington

100.

Copyright and Innovation: Responses to Marks, Masnick, and Picker

2013 Wisconsin Law Review Online
Number of pages: 16 Posted: 12 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 69 (378,333)

Abstract:

Loading...

copyright, innovation, creativity, music, record labels, napster, peer-to-peer (p2p)

101.

Brief Amici Curiae on Behalf of 70 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

First Circuit brief in In re: Loestrin 24 FE Antitrust Litigation, 2015
Number of pages: 45 Posted: 17 Jun 2015
Michael A. Carrier and Kenneth Wexler
Rutgers Law School and Wexler Wallace LLP
Downloads 67 (384,321)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Loestrin

102.

The U.S. Court of Appeals for the Third Circuit Concludes that the Actavis Ruling Applies to Non-Cash Payments (Lamictal)

e-Competitions Bulletin, No. 75208, August 2015
Number of pages: 4 Posted: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 66 (387,407)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, authorized generics, Hatch Waxman, brands, generics

103.

The U.S. Court of Appeals for Third Circuit Offers Misguided Analysis of Product Hopping

e-Competitions Bulletin, No. 81744, October 2016
Number of pages: 6 Posted: 31 Oct 2016
Michael A. Carrier
Rutgers Law School
Downloads 63 (396,811)

Abstract:

Loading...

Product Hopping, Drugs, Pharmaceuticals, Antitrust, Patent, Regulation, Doryx, Mylan, Warner Chilcott

104.

The U.S. District Court for the Northern District of Illinois Dismisses Antitrust Case Challenging Patent Thicket (Humira)

e-Competitions (No. 96364, Sept. 2020)
Number of pages: 7 Posted: 10 Sep 2020 Last Revised: 28 Nov 2020
Michael A. Carrier
Rutgers Law School
Downloads 60 (413,271)

Abstract:

Loading...

antitrust, patent thicket, settlement, sham, injury, Humira

105.

Four Proposals to Enhance Generic Competition (Presentation Slides)

FDA Testimony (2017)
Number of pages: 9 Posted: 18 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 59 (409,805)

Abstract:

Loading...

pharmaceuticals, drugs, generics, patents, REMS, citizen petitions, Hatch Waxman

106.

Pay-for-Delay: Who Does the Generic Industry Lobby Represent?

CPI Antitrust Chronicle, May 2020
Number of pages: 10 Posted: 28 May 2020
Michael A. Carrier
Rutgers Law School
Downloads 56 (420,134)

Abstract:

Loading...

Generics, AAM, Pay-for-Delay, Reverse-Payment Settlements, Impax, AB 824

107.

The California Supreme Court Cements Vigorous Scrutiny of Reverse-Payment Settlements (Cipro)

e-Competitions Bulletin, No. 73830, June 2015
Number of pages: 6 Posted: 09 Jul 2015
Michael A. Carrier
Rutgers Law School
Downloads 54 (427,157)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, state antitrust law, Cartwright Act

108.

The Industry that Cries Wolf: Pharma and Innovation

STAT: First Opinion, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 28 Oct 2019
Michael A. Carrier and Genevieve Tung
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 53 (430,852)

Abstract:

Loading...

pharmaceuticals, drugs, innovation

109.

The U.S. District Court for the Northern District of California Sets Student-Athletes' Antitrust Case for Trial (NCAA)

e-Competitions Bulletin, No. 87066, May 2018
Number of pages: 5 Posted: 12 Jun 2018
Michael A. Carrier
Rutgers Law School
Downloads 52 (434,428)
Citation 1

Abstract:

Loading...

Sports, antitrust, NCAA, amateurism, Jenkins, O'Bannon, Rule of Reason

110.

A Six-Step Solution to the PBM Problem

Health Affairs Blog, Aug. 30, 2018
Number of pages: 3 Posted: 12 Oct 2018
Michael A. Carrier
Rutgers Law School
Downloads 51 (438,104)

Abstract:

Loading...

PBM, pharmacy benefit manager, drug pricing, rebates

111.

Antitrust after the Interception: Of a Heroic Returner and Myriad Paths

Stanford Law Review, Vol. 55, October 2002
Number of pages: 15 Posted: 04 Dec 2002
Michael A. Carrier
Rutgers Law School
Downloads 51 (438,104)

Abstract:

Loading...

112.

U.S. Court Issues Concerning Ruling on Drug Patent Settlements (Loestrin)

e-Competitions Bulletin, No. 69705, October 2014
Number of pages: 5 Posted: 05 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 50 (441,842)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, Loestrin

113.

Don’t Die! How Biosimilar Disparagement Violates Antitrust Law

115 Northwestern University Law Review Online 119 (2020)
Number of pages: 27 Posted: 27 May 2020 Last Revised: 29 Oct 2020
Michael A. Carrier
Rutgers Law School
Downloads 49 (445,737)

Abstract:

Loading...

Pharmaceuticals, Drugs, Biosimilars, Biologics, Disparagement, Antitrust

114.

Statement by Michael A. Carrier to Senate Judiciary Committee on 'Intellectual Property and the Price of Prescription Drugs: Balancing Innovation and Competition'

Senate Judiciary Committee hearing May 7, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 06 Sep 2019
Michael A. Carrier
Rutgers Law School
Downloads 48 (453,512)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, sample denials, pay-for-delay settlements, citizen petitions, product hopping, patent thickets

115.

Brief for the American Antitrust Institute As Amicus Curiae in Support of Petition for Rehearing and Rehearing En Banc

U.S. Court of Appeals for Third Circuit
Number of pages: 16 Posted: 20 Oct 2016
Michael A. Carrier and Richard Brunell
Rutgers Law School and affiliation not provided to SSRN
Downloads 47 (453,512)

Abstract:

Loading...

product hopping, antitrust, patent, drugs, pharmaceuticals, Mylan, Warner Chilcott, Namenda

116.

Why the Supreme Court Should Deny Certiorari in King Drug

CPI Antitrust Chronicle (Sept. 2016)
Number of pages: 8 Posted: 24 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 47 (453,512)
Citation 1

Abstract:

Loading...

settlements, patent, antitrust, Actavis, pharmaceuticals, drugs, reverse payments, exclusive license

117.

Brief Amici Curiae of the American Antitrust Institute and Consumers Union

ED Pa Brief in In re: Wellbutrin XL Antitrust Litigation
Number of pages: 34 Posted: 02 Oct 2013
Michael A. Carrier
Rutgers Law School
Downloads 47 (453,512)

Abstract:

Loading...

patent, antitrust, settlement, authorized generics, drugs, pharmaceuticals, Hatch Waxman, reverse payment, exclusive license

118.

How Biosimilar Disparagement Violates Antitrust Law

Bloomberg Law (Nov. 16, 2020)
Number of pages: 3 Posted: 23 Dec 2020
Michael A. Carrier
Rutgers Law School
Downloads 46 (461,584)

Abstract:

Loading...

Pharmaceuticals, Drugs, Biosimilars, Biologics, Disparagement, Antitrust

119.

Eliminate Statutory Damages for Secondary Infringers

Department of Commerce Internet Policy Task Force Comment, 2014, Innovation for the 21st Century paperback, Oxford University Press, USA, 2011
Number of pages: 19 Posted: 17 Jan 2014 Last Revised: 19 Jan 2014
Michael A. Carrier
Rutgers Law School
Downloads 44 (465,757)

Abstract:

Loading...

copyright, statutory damages, innovation, secondary liability

120.

FTC Reverses Administrative Law Judge Decision, Finding Section 5 Violation for Reverse-Payment Settlement (Impax)

e-Competitions Bulletin, No. 90331, May 2019, Rutgers Law School Research Paper
Number of pages: 9 Posted: 29 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 42 (474,325)

Abstract:

Loading...

pharmaceuticals, drugs, settlements, reverse payment, Impax, FTC, Commission

121.

Statement by Michael A. Carrier to Senate Judiciary Committee

Senate Judiciary Committee hearing May 7, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 29 May 2019
Michael A. Carrier
Rutgers Law School
Downloads 39 (487,537)

Abstract:

Loading...

drugs, pharmaceuticals, antitrust, samples, settlements, citizen petitions, product hopping, patent thicketing

122.

Addressing Abusive Citizen Petitions

FDA Request for Comments on Citizen Petitions, 2018
Number of pages: 1 Posted: 12 Nov 2018
Michael A. Carrier
Rutgers Law School
Downloads 39 (487,537)

Abstract:

Loading...

citizen petitions, section 505(q), FTC, Congress, generics

123.

IP and Competition: Context, Test, and Balance

Comment for FTC Hearings on Competition and Consumer Protection in the 21st Century
Number of pages: 1 Posted: 27 Aug 2018
Michael A. Carrier
Rutgers Law School
Downloads 39 (487,537)

Abstract:

Loading...

IP, competition, FTC, pharmaceuticals, consumer welfare, patent holdup

124.

The U.S. Court of Appeals for the Third Circuit Applies an Appropriate Post-Actavis Pleading Standard (Lipitor)

e-Competitions Bulletin, No. 84937, October 2017
Number of pages: 9 Posted: 20 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 39 (492,018)

Abstract:

Loading...

Drugs, Patents, Settlements, Pleading, Actavis, Lipitor, Effexor

125.

Responses to Questions for the Record by Senators Grassley, Klobuchar, and Blumenthal for Senate Judiciary Committee Hearing on 'IP and the Price of Prescription Drugs: Balancing Innovation and Competition'

Responses to Questions for the Record by Senator Grassley, Senator Klobuchar, and Senator Blumenthal, Rutgers Law School Research Paper
Number of pages: 9 Posted: 06 Sep 2019
Michael A. Carrier
Rutgers Law School
Downloads 38 (492,018)

Abstract:

Loading...

pharmaceuticals, drugs, PBMs, patent examination, citizen petitions, product hopping, patent thicketing, killer acquisitions

126.

The 'Equity of the Statute' and Copyright Law: Three Critiques

163 University of Pennsylvania Law Review Online 377 (2015)
Number of pages: 16 Posted: 04 Dec 2015 Last Revised: 09 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 37 (496,611)

Abstract:

Loading...

copyright, equity, incentives, access, Kirtsaeng, Feist, Harper & Row, Reed Elsevier, Fogerty, Petrella, Sony, Grokster, Aereo

127.

Statement by Michael A. Carrier to House Judiciary Committee on 'Antitrust Concerns and the FDA Approval Process'

House Judiciary Committee hearing, July 24, 2017
Number of pages: 3 Posted: 26 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 36 (501,249)

Abstract:

Loading...

antitrust, patent, drugs, pharmaceuticals, REMS, CREATES Act, settlements, citizen petitions

128.

Answer to Iancu's SEP Policy Call Is in Plain Sight

Law 360, Forthcoming, Rutgers Law School Research Paper
Number of pages: 4 Posted: 08 Oct 2019
Michael A. Carrier
Rutgers Law School
Downloads 34 (511,011)

Abstract:

Loading...

standards, patents, antitrust

129.

Why Property Law Does Not Support the Antitrust Abandonment of Standards

57 Houston Law Review 265 (2019)
Number of pages: 20 Posted: 16 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 33 (516,071)

Abstract:

Loading...

antitrust, patent holdup, standards, property, FRAND

130.

Statement by Michael A. Carrier to Health Subcommittee of House Committee on Energy & Commerce

House Subcommittee of House Committee on Energy & Commerce hearing March 13, 2019, Rutgers Law School Research Paper
Number of pages: 2 Posted: 14 Mar 2019
Michael A. Carrier
Rutgers Law School
Downloads 33 (516,071)

Abstract:

Loading...

Pharmaceuticals, Drugs, Antitrust, Samples, Settlements, Orange Book, Purple Book

131.

Motion for Leave to File Brief and Brief Amicus Curiae in Support of Defendant's Opposition to Plaintiff's Motion for Preliminary Injunction

U.S. District Court for the Eastern District of California, 2019
Number of pages: 24 Posted: 09 Dec 2019
Michael A. Carrier
Rutgers Law School
Downloads 31 (531,643)

Abstract:

Loading...

drug patent settlements, reverse payments, AB 824, California statute

132.

Don't Ditch Antitrust's Role in Product Hopping: A Response to Pace and Adam

33 Antitrust 72 (2019), Rutgers Law School Research Paper
Number of pages: 2 Posted: 28 Apr 2019
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 30 (531,643)

Abstract:

Loading...

antitrust, product hopping, pharmaceuticals, drugs, innovation

133.

Comments on Proposed Update on Intellectual Property Licensing Guidelines

Number of pages: 1 Posted: 03 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 30 (531,643)

Abstract:

Loading...

intellectual property, agencies, regulation, industry, patents

134.

Five Proposals to Stop the Games and Encourage a Robust Biosimilar Market

FDA Request for Comments on Biologics Marketplace, 2018
Number of pages: 1 Posted: 12 Oct 2018
Michael A. Carrier
Rutgers Law School
Downloads 28 (542,982)

Abstract:

Loading...

FDA, competition, antitrust, REMS, citizen petitions, FTC

135.

How Biologics Cos. Disparage Biosimilars And How To Stop It

Law360 (Aug. 4, 2020)
Number of pages: 4 Posted: 10 Sep 2020
Michael A. Carrier
Rutgers Law School
Downloads 24 (567,324)

Abstract:

Loading...

biologics, biosimilars, disparagement

136.

Essential Changes to Shared REMS

Comment to Proposed FDA Regulations, 2018
Number of pages: 1 Posted: 01 Aug 2018
Michael A. Carrier
Rutgers Law School
Downloads 21 (586,640)

Abstract:

Loading...

REMS, Drugs, Pharmaceuticals, Brands, Generics, FDA

137.

DOJ Giving Cover to Monopolizing Firms that Breach Antitrust Rules

The Hill (Oct. 11, 2018), Rutgers Law School Research Paper
Number of pages: 3 Posted: 16 Jan 2019
Michael A. Carrier
Rutgers Law School
Downloads 19 (599,959)

Abstract:

Loading...

standards, patents, antitrust, holdup, FRAND

138.

REMS Patents Should Not be Listed in Orange Book

FDA Request for Comment on Listing of Patent Information in Orange Book, 2020
Number of pages: 1 Posted: 10 Sep 2020
Michael A. Carrier
Rutgers Law School
Downloads 17 (613,089)

Abstract:

Loading...

REMS patents, Orange Book

139.

Solving the 'Parking' Problem in the Drug Monopoly Game

The Hill (December 2019)
Number of pages: 3 Posted: 02 Jun 2020
Michael A. Carrier
Rutgers Law School
Downloads 17 (613,089)

Abstract:

Loading...

settlements, generics, Hatch-Waxman Act

140.

Brief Amicus Curiae in Support of Appellee's Answering Brief

U.S. Court of Appeals for the Ninth Circuit, 2020, Rutgers Law School Research Paper
Number of pages: 31 Posted: 06 Mar 2020
Michael A. Carrier
Rutgers Law School
Downloads 17 (613,089)

Abstract:

Loading...

drug patent settlements, reverse payments, AB 824, California statute

141.

Statement by Michael A. Carrier to House Energy & Commerce Committee (Subcommittee on Consumer Protection and Commerce)

House Subcommittee of House Energy & Commerce Committee hearing September 19, 2019 , Rutgers Law School Research Paper
Number of pages: 3 Posted: 22 Oct 2019
Michael A. Carrier
Rutgers Law School
Downloads 15 (626,888)

Abstract:

Loading...

antitrust, pharmaceuticals, drugs, product hopping

142.
Downloads 8 (677,272)

Abstract:

Loading...

product hopping, drugs, pharmaceuticals, FTC

143.

INSIGHT: New Statement on Standard-Essential Patents Relies on Omissions, Strawmen, Generalities

Bloomberg Law Insight, 2020
Number of pages: 4 Posted: 08 Apr 2020
Michael A. Carrier
Rutgers Law School
Downloads 4 (706,677)

Abstract:

Loading...

Antitrust, Patent, Holdup, Standards, DOJ, PTO, NIST

144.

Pharmaceutical Antitrust: What the Biden Administration Can Do

Concurrences
Number of pages: 4
Michael A. Carrier
Rutgers Law School
Downloads 0

Abstract:

Loading...

Antitrust, pharmaceuticals, drugs, pay-for-delay settlements, product hopping, biosimilars